Highlights and Quick Summary
- EPS Growth (basic) for the quarter ending June 30, 2023 was 139.34% (a -2260.31% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (basic) increased by 3596.02%
- Annual EPS Growth (basic) for 2022 was -7.69% (a 639.42% increase from previous year)
- Annual EPS Growth (basic) for 2021 was -1.04% (a -95.46% decrease from previous year)
- Annual EPS Growth (basic) for 2020 was -22.93% (a -126.9% decrease from previous year)
- Twelve month EPS Growth (basic) ending June 30, 2023 was 41.6% (a -834.98% decrease compared to previous quarter)
- Twelve month trailing EPS Growth (basic) decreased by -182.67% year-over-year
Trailing EPS Growth (basic) for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 41.6% | -5.66% | -13.4% | -50.32% |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (basic) of ARAVIVE, INC
Most recent EPS Growth (basic)of ARAV including historical data for past 10 years.Interactive Chart of EPS Growth (basic) of ARAVIVE, INC
ARAVIVE, INC EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 139.34% | -6.45% | – | – | – |
| 2022 | 25.81% | 3.77% | -74.29% | -40.91% | -7.69% |
| 2021 | -148.0% | 19.7% | -9.37% | 38.89% | -1.04% |
| 2020 | 28.57% | -22.22% | -18.52% | -71.43% | -22.93% |
| 2019 | 92.74% | 50.0% | 83.33% | 71.99% | 85.24% |
| 2018 | -192.35% | 87.14% | 74.04% | 70.59% | 26.4% |
| 2017 | 235.94% | -52.17% | -38.67% | -3.66% | 22.51% |
| 2016 | 7.25% | -33.33% | -11.94% | -3.8% | -9.5% |
| 2015 | -6.16% | -21.05% | -86.11% | 95.1% | 35.31% |
| 2014 | 96.75% | 97.7% | 98.81% | -1941.76% | -120.6% |
| 2013 | -2973.86% | -4240.36% | -8297.11% | – | 54.67% |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology